IndoVac
 | |
| Vaccine description | |
|---|---|
| Target | SARS-CoV-2 |
| Vaccine type | Protein subunit |
| Clinical data | |
| Trade names | IndoVac |
| Routes of administration | Intramuscular |
| Part of a series on the |
| COVID-19 pandemic |
|---|
 |
|
|
Medical response |
|
.svg){kind=small} COVID-19 portal |
IndoVac is a recombinant protein subunit COVID-19 vaccine,[1][2] developed by Indonesian pharmaceutical company Bio Farma and Baylor College of Medicine in Houston, Texas.[1][2] It is the world's first officially halal certified COVID-19 vaccine,[3] but the most popular existing vaccines had already been widely endorsed as Halal by various Islamic groups.[4][5] The vaccine was officially launched by President Joko Widodo on 13 October 2022.[6]
Technology
The vaccine consists of an active yeast-based receptor binding domain (RBD) of the SARS‑CoV‑2 spike protein.[7] With no animal cells or products being used in its production,[3] IndoVac received its halal certificate from the Halal Product Assurance Organizing Body of the Ministry of Religious Affairs on 29 July 2022.[8]
Manufacturing
In October 2022, President Joko Widodo announced that Bio Farma will produce up to 20 million doses of the vaccine for the initial first phase of production in the same year. The production capacity will be increased to 40 million doses in 2023.[1]
References
- ^ a b c "Indonesian Pharmaceutical Company Bio Farma Ready to Produce 'IndoVac' Covid-19 Vaccines, a New Milestone for Indonesia's Independence in the Pharmaceutical Sector". Bio Farma. 13 September 2022.
- ^ a b "Texas-Developed Patent-Free COVID-19 Vaccine Technology Receives Emergency Use Authorization In Indonesia". Texas Children's Hospital. Retrieved 14 October 2022.
- ^ a b "Dr. Peter Hotez's halal COVID-19 vaccine approved for use in Indonesia". Houston Chronicle. 3 October 2022.
- ^ "Islamic federation certifies coronavirus vaccines as Halal, but warns misinformation is widespread". SBS Language.
- ^ Waqar A. "Is the COVID-19 vaccine Halal?". SBS Language. Retrieved 16 October 2022.
- ^ "Jokowi launches domestically manufactured IndoVac COVID-19 vaccine". Antara. 13 October 2022.
- ^ "BPOM Terbitkan EUA Vaksin Indovac dan Vaksin AWcorna" [BPOM issues EUA for IndoVac and AWcorna vaccines]. The Indonesian Food and Drug Authority (in Indonesian). 30 September 2022.
- ^ "Kantongi Sertifikat Halal dan Aman, Bio Farma Siap Ekspor Vaksin Covid-19 IndoVac ke Afrika" [With the halal and safety certificates now in hand, Bio Farma is ready to export IndoVac Covid-19 vaccine to Africa]. Pikiran Rakyat (in Indonesian). 11 October 2022.
| Development | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Classes | |||||||||||
| Administration | |||||||||||
| Vaccines |
| ||||||||||
| Inventors/ researchers | |||||||||||
| Controversy | |||||||||||
| Related | |||||||||||
| |||||||||||
| Locations | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Response | |||||||||
| Institutions |
| ||||||||
| People |
| ||||||||
| Timeline | |||||||||
| Data (templates) | |||||||||
- CS1 Indonesian-language sources (id)
- Articles with short description
- Short description matches Wikidata
- Use dmy dates from October 2022
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drugs that are a vaccine
- Science and technology in Indonesia
- Protein subunit vaccines
- Products introduced in 2022